LEGAL UPDATE | No. 31
Legal analysis as of October 7, 2026 | Corrected October 20, 2026
SAKURA Law Office | Managing Partner Kenshiro Michishita
SAKURA Law Office has published the thirty-first edition of the Legal Update series by Managing Partner Kenshiro Michishita, addressing management buyouts (MBOs), going-private transactions led by controlling shareholders and the protection of public shareholders in Japan. These transactions can be powerful instruments for portfolio restructuring, the elimination of parent-subsidiary listings, long-term investment outside the pressures of the public market and the acceleration of strategic change. They also create one of the clearest structural conflicts in listed-company M&A: the people who possess the best information about the target, or already exercise influence over it, may also have an economic interest in acquiring the remaining shares at the lowest possible price.
Japanese practice has increasingly responded to that conflict by focusing not only on the level of the premium, but on the architecture of the decision-making process. The Ministry of Economy, Trade and Industry’s 2019 Fair M&A Guidelines remain the central best-practice framework. Tokyo Stock Exchange then strengthened its listing framework with revisions effective July 22, 2025. For covered MBOs and subsidiary conversions, the revised Code of Corporate Conduct requires a listed company to obtain an opinion from an independent special committee on whether the transaction is fair to general shareholders and to make necessary and sufficient timely disclosure. The significance of the change is substantive: a special committee is no longer appropriately viewed as a body that merely confirms a conclusion reached elsewhere. It is expected to examine the merits of the transaction, the fairness of its terms and the fairness of the process, and to explain why the proposed allocation of value is fair to shareholders who do not participate on the acquiring side. [4] [5]
The transaction must also be designed across several legal regimes at once. Japan’s amended tender offer regime took effect on May 1, 2026, including the new 30% threshold framework. The tender offer, the target board’s opinion, financing, minimum tender conditions and the post-offer squeeze-out therefore need to be planned as one sequence rather than as separate workstreams. If the acquirer reaches the statutory 90% voting-right threshold for a special controlling shareholder, the Companies Act provides a share cash-out procedure under Articles 179 et seq. If it does not, a consolidation of shares is commonly used to cash out the remaining shareholders, subject to shareholder approval and statutory protections for dissenting shareholders. Each route has its own approval mechanics, remedies and litigation risks. [3]
Judicial review of price should be considered against the Supreme Court’s First Petty Bench decision of July 1, 2016. It concerned a tender offer by majority shareholders followed by acquisition of all shares of a class subject to a class-wide acquisition provision. The Court examined safeguards against conflicts, disclosure that the second-step acquisition would use the tender price, the fairness of the process and unexpected changes in the transaction’s underlying circumstances. The decision did not directly decide the modern share cash-out or share-consolidation procedures. It nevertheless provides a concrete starting point for understanding why contemporaneous decisions and disclosure matter in later price proceedings. [6]
This Update analyses the legal and practical framework as of October 7, 2026. It treats an MBO or controlling-shareholder going-private transaction as a continuous governance problem running from the first credible proposal through committee formation, valuation and negotiation, tender offer execution, squeeze-out, appraisal or injunction risk and the target’s pre-existing governance arrangements. The objective is not to create a checklist of formalities, but to identify what boards, special committees, private equity sponsors, financial institutions and foreign counsel need to decide in order to produce a transaction that is both executable and capable of being defended after the fact.
Executive Summary
The central legal and practical challenge in a Japanese MBO or controlling-shareholder going-private transaction is not simply whether the offer price includes an attractive premium. It is whether the target can create a decision-making process that genuinely represents the interests of shareholders who are not participating on the buyer side. The July 22, 2025 TSE reforms sharpened this point by requiring, for covered transactions, an independent special committee opinion addressing fairness to general shareholders. In practical terms, the committee should be formed while material terms can still move, should have access to the information and advisers needed to test management assumptions, and should be able to seek better terms, examine credible alternatives and recommend that the transaction not proceed if the outcome is not acceptable. [4] [5]
Fairness of consideration is correspondingly broader than a valuation range or a headline premium. The analysis should test the target’s standalone value, the business plan used for valuation, assumptions embedded in DCF or other methodologies, value that may be unlocked by going private, the allocation of synergies or other transaction-specific gains, the availability and credibility of competing proposals, the effectiveness of any market check and the extent to which negotiation actually improved the economics for public shareholders. Majority-of-the-minority conditions, market checks and fairness opinions may be powerful procedural protections, but Japanese law does not make each of them a uniform statutory condition for every MBO. Their usefulness depends on the strength of the conflict and on the other safeguards in place.
The tender offer and the squeeze-out should be designed from the outset as a single transaction. Where the acquirer becomes a special controlling shareholder with at least 90% of the voting rights, a demand for the cash-out of shares under Articles 179 et seq. of the Companies Act may be available. Where the 90% threshold is not achieved, a consolidation of shares is commonly used to create fractional interests that are cashed out following a special resolution of the shareholders. Statutory injunction, appraisal and price-determination mechanisms differ across structures. The record created before launch — the business plan, valuation work, special committee minutes, negotiation history, competing proposals and disclosure rationale — therefore becomes the core evidentiary record if the transaction is challenged later.
The July 1, 2016 Supreme Court decision illustrates when a tender price formed through generally fair procedures may be respected in the subsequent acquisition of all shares subject to a class-wide acquisition provision. The existence of a committee alone does not settle fairness. The Court’s reasoning also preserves the significance of special circumstances involving an unexpected change in the transaction’s underlying assumptions. Counsel should not transfer the result mechanically to a different statutory squeeze-out procedure: the practical inquiry remains the effectiveness of conflict controls, information, price formation and the connection between the two steps. [6]
For boards, General Counsel and sponsors, the final point is temporal. Independence cannot always be manufactured after an MBO proposal arrives. TSE’s 2026 reforms concerning minority-shareholder protection and the July 2026 revision of Japan’s Corporate Governance Code reinforce the importance of independent directors, effective boards and transparent management of relationships with controlling or quasi-controlling shareholders in ordinary times. A listed subsidiary or founder-controlled company that already has credible independent governance will be better positioned to respond quickly, negotiate with authority and withstand scrutiny when a going-private proposal emerges. [7] [9]
1. The starting point is structural conflict, not the premium
In a classic MBO, members of target management may invest alongside the acquisition vehicle, roll a portion of their equity, receive post-closing incentives or continue in senior management after the company is taken private. In a controlling-shareholder squeeze-out, the buyer already has the power to influence the target before the transaction begins. Neither structure is inherently unlawful or commercially suspect. Both can have compelling strategic justifications. The problem is that the ordinary price-forming dynamic of an arm’s-length sale may be weakened precisely because the buyer side has superior information, influence over management or both.
Directors of a Japanese stock company owe statutory duties of care and loyalty to the company. In an MBO, however, a director who expects to participate in the buyer consortium, retain a material economic interest or receive meaningful post-closing benefits may not be able to act as an ordinary representative of the selling side when the exit price for public shareholders is being set. The same concern can arise where a director has significant ties to a controlling shareholder. It is therefore insufficient to focus only on whether conflicted directors abstain from a final board vote. The legal and governance analysis should identify who receives the first proposal, who controls the flow of diligence information, who prepares and modifies the business plan, who instructs the financial adviser, who decides whether other bidders may be contacted, and who participates in each stage of price negotiation.
METI’s Fair M&A Guidelines respond to this problem through a principles-based framework directed at MBOs and acquisitions of controlled companies by controlling shareholders. The Guidelines are not a statute, but they have become a central reference point for Japanese listed-company practice and for evaluating whether a process adequately addresses structural conflicts. Their core premise is that enhancement of corporate value and protection of shareholder interests should be pursued together, and that procedural safeguards should be selected and operated in light of the conflict actually present in the transaction.
TSE’s July 2025 reforms moved the listed-company framework further in the same direction. The revised Code of Corporate Conduct covers MBOs and specified transactions by controlling shareholders or other related companies that are expected to result in delisting, including certain share exchanges, share transfers, consolidations of shares and share cash-outs. For covered transactions, the listed company must obtain an opinion from an independent special committee addressing fairness to general shareholders and must make necessary and sufficient timely disclosure. TSE’s English explanatory materials expressly describe the change from the former formulation focused on whether minority-shareholder interests would be harmed to an opinion on whether the transaction is fair to general shareholders. That shift makes the committee’s role one of affirmative fairness review rather than negative harm avoidance. This perimeter should not be extended automatically to every second-step acquisition following a tender offer by a previously independent third party that becomes controlling only through that offer. TSE also recognises limited exceptions involving opinions from independent persons. The applicable listing provisions and practical guidance must therefore be examined for the actual transaction. [5]
2. Design the transaction from the first proposal through the squeeze-out
A Japanese going-private transaction is implemented through several formally distinct steps: a proposal, target review, special committee process, due diligence, price negotiation, tender offer, target opinion, settlement, squeeze-out and delisting. The legal architecture should nevertheless be built as a single transaction. The parties should begin with the desired end-state — who will own what percentage of voting rights, which squeeze-out route will be available, what regulatory approvals are required and when the target is expected to delist — and then work backwards to the tender conditions, financing commitments, disclosure and shareholder approvals needed to reach that end-state.
The tender offer framework is now especially important because the reforms to Japan’s tender offer rules that took effect on May 1, 2026 changed the acquisition threshold architecture, including the introduction of the 30% rule. An MBO of a listed company will ordinarily use a tender offer as the principal acquisition mechanism, but the analysis cannot stop with the offer itself. Pre-existing holdings, holdings of specially related persons, any proposed market purchases and the sequence of acquisitions need to be mapped under the current Financial Instruments and Exchange Act and implementing rules. Compliance with tender offer regulation and procedural fairness under the TSE/METI framework are separate questions; a transaction needs to satisfy both. [3]
Article 179 generally uses a threshold of at least 90% of all shareholder voting rights for a special controlling shareholder. The articles of incorporation may prescribe a higher percentage, and the statute permits the specified aggregation of holdings of qualifying wholly owned entities. The test is therefore not necessarily the acquirer’s direct shareholding alone. Where the statutory conditions are met, Articles 179 et seq. permit a demand for the sale of the remaining shares through the share cash-out procedure. Target-board approval is required in a company with a board of directors, and remaining shareholders retain specified injunction and court price-determination remedies. Reaching the threshold can streamline implementation; it does not eliminate the need for a defensible consideration and approval process. [1]
Where the 90% threshold is not reached, a consolidation of shares is commonly used as the second-step squeeze-out. The consolidation ratio is structured so that the holdings of the remaining public shareholders become fractional shares, with cash paid through the statutory disposition of the fractions. A special resolution of the shareholders is required. The Companies Act provides dissenting shareholders with statutory rights, including appraisal rights in relation to the consolidation and injunctive relief in defined circumstances. Because the tender offer price ordinarily anchors the cash amount paid in the squeeze-out, defects in the first-step price-setting process can reappear in the second step as appraisal or fairness disputes. [1]
The practical consequence is that the target should consider the entire exit path when it expresses its opinion on the tender offer. Shareholders need to understand not only the tender offer price but also the planned squeeze-out method, expected timing, the treatment of non-tendering shareholders and the statutory rights that will remain available. The buyer, in turn, should plan both the 90%-plus route and the below-90% fallback, together with financing, tax, foreign investment review, competition law and other closing conditions. Treating the squeeze-out as a matter to be decided only after the tender offer succeeds creates unnecessary legal and execution risk.
3. The special committee must shape the terms, not merely approve them
The Fair M&A Guidelines state that, once a target has received a concrete, feasible and bona fide acquisition proposal, a special committee should be established as promptly as practicable. The timing matters because the committee’s effectiveness depends on whether important terms are still open. If management and the buyer have already fixed the price, diligence scope, exclusivity arrangements, rollover economics and key post-closing arrangements, an independent committee formed later may have little practical ability to do anything other than approve or reject a substantially completed transaction. [4] [5]
Independence must be examined in substance. TSE’s current framework looks not only to independence from the buyer, controlling shareholder or other related party, but also to independence from the outcome of the transaction. Independent outside directors will often be well placed to serve because they understand the business and already owe governance responsibilities to the target. Depending on the circumstances, outside statutory auditors or genuinely independent legal, accounting or financial experts may also participate. What matters is whether the committee can credibly apply the interests of general shareholders as the reference point for its decisions, taking into account fees, continuing engagements, relationships with financing sources and any other factor that could create a reasonable concern about independence.
The mandate is equally important. A committee that can only receive presentations from management is not equivalent to a committee that can obtain information directly, retain its own advisers where necessary, question the buyer, require revisions to assumptions, request improved terms, evaluate competing proposals and recommend that the transaction not proceed. TSE’s English materials on current practice emphasise that an effective special committee is expected to have a real role in negotiations. The degree of direct involvement may vary by transaction, but the committee should control or meaningfully supervise the target-side process rather than merely review a record created by conflicted participants.
TSE’s current practical guidance requires the committee’s opinion to explain its examination and the basis for the final conclusion from three connected perspectives: the merits of the transaction, the fairness of the terms and the fairness of the process. The merits analysis asks whether the going-private transaction contributes to the target’s corporate value. The terms analysis extends beyond the headline price to the method and type of consideration and, critically, the consultation and negotiation process with the acquirer. The process analysis considers whether structural conflicts have been contained and whether general shareholders will receive sufficient information to make an informed decision. A defensible opinion integrates all three rather than treating them as separate boxes to be checked. [5]
The board of directors does not, however, transfer its own statutory responsibility to the committee. The board must determine its position on the tender offer and later corporate actions in light of the committee’s work, while appropriately excluding or limiting the participation of conflicted directors. The strongest process therefore defines, at the beginning of the transaction, the roles and information channels of the committee, non-conflicted directors, management, financial advisers and legal counsel. It should make clear who is authorised to negotiate, who can access which information and who decides whether alternatives are credible.
4. Price fairness is a question of measuring and allocating value
Market participants naturally focus on the premium to the unaffected market price. Premium analysis is useful and is expected in Japanese disclosure practice, but it is not the same as a conclusion that the consideration is fair. A 30% or 40% premium may have very different significance depending on whether the market price was temporarily depressed, whether the company had undisclosed improvement initiatives, whether recent guidance was unusually conservative, or whether material value created by the going-private plan would otherwise accrue almost entirely to the sponsor or participating management.
The better starting point is to separate standalone value from transaction-specific value. What value would public shareholders reasonably expect to retain if the company remained listed and pursued its credible standalone strategy? What additional value may be created by the change of ownership, leverage, restructuring, cost reductions, accelerated investment or combination with the buyer? What part of those gains depends on risks or capital contributed by the buyer, and what part derives from assets, business opportunities or information already belonging to the target? Fairness analysis is therefore not only measurement; it is also the allocation of incremental value between the buyer and shareholders being cashed out.
Valuation reports should be examined on that basis. Market-price analysis, comparable-company analysis, DCF and other methodologies each have a role, but a special committee should not treat the fact that the proposed price falls somewhere within an adviser’s valuation range as the end of its inquiry. DCF results can move materially with assumptions concerning sales growth, margins, capital expenditure, working capital, terminal value and discount rates. Where management participating in the MBO has significant involvement in preparing the business plan, the committee should test whether forecasts are consistent with the company’s prior internal planning and public guidance, whether deviations are explained, and whether assumptions have been changed in a manner that depresses the standalone valuation.
Substantive negotiation is itself a fairness safeguard. An independent committee or a negotiating team under its control should be willing to reject an opening proposal, use valuation and strategic information to seek price improvements and record the reasons for each material decision. The same final number carries a different evidentiary and governance meaning if it was simply accepted at the outset than if it emerged from a process in which an independent body had credible authority to say no, pressed for improved terms and tested the buyer’s asserted constraints.
Other safeguards should be understood in context. An active market check may expose the target to competing price discovery, but it must be balanced against confidentiality, employee and customer disruption and execution certainty. A passive market check may still have value where transaction documents preserve a realistic ability to consider a superior proposal. A majority-of-the-minority condition can reduce the ability of the controlling side to determine the result, but may in a concentrated share register give a relatively small group of holders an unusually powerful blocking position. A fairness opinion can provide independent financial analysis, but it does not substitute for legal fairness or an effective process. The Fair M&A Guidelines deliberately favour a combination of safeguards calibrated to the transaction rather than a mechanical requirement that every available measure be used in every case.
Accordingly, the target’s explanation should not be that it completed a standard checklist. It should identify the actual conflict risks in the case, the safeguards selected in response, and why the board and special committee concluded that those safeguards were sufficient to protect general shareholders. That transaction-specific reasoning is far more important than the number of procedural devices employed.
5. The July 1, 2016 Supreme Court decision: fair two-step acquisitions and price review
The First Petty Bench decision of July 1, 2016 (Heisei 28 (Kyo) Nos. 4–20) concerned the acquisition price of shares subject to a class-wide acquisition provision under the former Article 172(1) of the Companies Act. A majority-shareholder group had made a tender offer and announced a subsequent acquisition at the same price. The Court rejected the lower court’s market-based upward adjustment and fixed the acquisition price at JPY 123,000 per share. The case did not determine a share-exchange ratio or a sale price under Article 179. [6]
The holding depended on generally fair procedures, including measures such as independent committee or expert involvement to remove arbitrariness arising from conflicts, and advance disclosure of equal pricing in the second step. In that setting, the tender price should be used absent special circumstances sufficient to establish an unexpected change in the transaction’s underlying circumstances. The existence of an offer price was therefore not, by itself, dispositive. [6]
This is not a general rule that developments after announcement can always be disregarded. The fairness of price formation, the explanation of the two-step terms and changes in the underlying circumstances remain material. Justice Koike’s concurring opinion discusses the court’s role in examining substantive procedural fairness in greater detail; that explanatory opinion should be distinguished from the Court’s holding. [6]
For a contemporary MBO, the practical question is whether the tender decision and subsequent exit route can be understood from one coherent body of information. A recommendation to tender accompanied by uncertainty over the second-step consideration, timing, conditions or shareholder rights may leave public holders unable to evaluate their actual alternatives. Transaction documents, the target opinion, the special committee’s reasoning and the later corporate action should explain a consistent pricing basis and treatment. This is a practical implication of the case, not a statement that the former Article 172 procedure and modern statutory routes have identical conditions or remedies. [6]
If material earnings information, an asset disposal, a competing proposal or a major business development emerges after announcement, the team should assess rather than mechanically preserve the original price. Was the development already reflected in the pricing assumptions? Is it material to value, execution or shareholder choice? Does it require renewed committee consideration or supplemental disclosure? Distinguishing ordinary market movement from transaction-specific changes, and recording the materials and reasons considered by the committee, board and advisers, creates a defensible record for a later price dispute. Reconsideration is not itself an admission that the original price was unfair. [6]
The decision should consequently not be used as an immunity clause stating that a committee prevents judicial repricing. Transaction structure, relationships, actual negotiation, valuation assumptions, information given to shareholders and subsequent developments must remain capable of scrutiny. The fairness explanation required by the 2025 TSE reforms should draw on the same contemporaneous record. Sound process connects price formation and dispute preparedness by making the original commercial judgment traceable; it does not seek to replace that judgment with a standard recital that every procedural safeguard was formally present. [6]
6. Execution and litigation begin with the same contemporaneous record
A transaction team must design disclosure around the decisions that general shareholders actually need to make. The target’s timely disclosure should explain the purpose of the MBO or going-private transaction, why the board believes it will enhance corporate value, how the price was determined, the relevant premium analysis, the negotiation history, the composition and independence of the special committee, the committee’s meetings and material deliberations, relationships involving financial advisers and valuation providers, other procedural safeguards, and the intended squeeze-out following the tender offer. TSE’s requirement for necessary and sufficient disclosure is not satisfied merely by producing a long document. The disclosure should identify the facts and reasons that materially drove the decision.
The same principle applies internally. Business plans, valuation materials, committee papers and minutes, correspondence with the buyer, price proposals, analyses of competing bids, board materials and key adviser presentations should be preserved in a coherent form that allows the decision to be reconstructed. If a dispute arises two years later, it will be difficult to explain from memory why a particular forecast was used, why a further price increase was not pursued, why another potential bidder was not contacted, or why exclusivity was accepted. Transaction records are not litigation narratives written in advance. Their purpose is to discipline the decision while it is being made and to allow a third party to follow the reasoning later.
The buyer side has an equally important governance role. A private equity sponsor or foreign strategic buyer should consider when and how it approaches management, the timing of rollover arrangements, post-closing incentives and roles, the scope of information shared with management, financing conditions, exclusivity and break fees, and the treatment of a superior proposal. If the sponsor and management settle detailed personal economics too early, the target’s independent process may be compromised or appear constrained, which can reduce rather than increase deal certainty. Buyer-side counsel should therefore distinguish terms that legitimately need early alignment from matters that should remain subject to negotiation through the target’s independent process.
Minority-shareholder remedies also need to be built into the execution plan. A demand for share cash-out by a special controlling shareholder, a consolidation of shares and a statutory reorganisation each have different injunction, appraisal or price-determination mechanisms and different procedural deadlines. Those rights should not be treated as unusual post-closing litigation. They are part of the legal structure that shareholders receive when the transaction is launched. The timetable, disclosure, financing and litigation strategy should anticipate them from the outset.
Seen in that light, a fair process is not an obstacle to speed. Early conflict mapping, a well-authorised special committee, disciplined information flows and documented decisions reduce the risk of late-stage changes in the company’s explanation, shareholder backlash, competing bids that expose weaknesses in the process, postponed meetings, injunction applications and appraisal litigation. Deal certainty and minority-shareholder protection are not opposites; a credible process can strengthen both.
7. Independence should exist before the MBO proposal arrives
Some governance weaknesses cannot be cured quickly once a going-private proposal has been received. In July 2026, TSE adopted further reforms directed at minority-shareholder protection, particularly for listed companies with shareholders exercising substantial influence. Among other measures, the reforms introduce additional disclosure concerning minority shareholders’ support for director elections at certain listed companies with a 40% or greater voting-right holder and revise aspects of the independence framework for independent officers. Certain elements apply from annual general meetings for fiscal years ending on or after December 1, 2026; as of the date of this Update, those elements should therefore be distinguished from rules already in operation. [7] [8]
Japan’s Corporate Governance Code was also revised in July 2026, together with related TSE listing rules. The revision places renewed emphasis on sustainable growth, growth investment and the substantive effectiveness of the board. For MBO practice, the significance is broader than any single provision. A board that has routinely examined corporate value, capital allocation, portfolio strategy and relationships with major shareholders from an independent perspective is better equipped to assess a going-private proposal than a board that attempts to become independent only when the controlling shareholder presents a transaction. [9] [11]
Listed subsidiaries, founder-controlled companies and other issuers with a shareholder capable of exerting substantial influence should therefore prepare before any transaction exists. The composition and independence of outside directors, access to information, policies for transactions with controlling shareholders, board evaluation, processes for creating and approving the business plan, and the treatment of conflicts should be reviewed in ordinary times. Those arrangements determine whether, when a proposal arrives, the company can identify genuinely independent special committee members, establish a credible standalone plan and negotiate without relying on information controlled by the acquiring side.
The practical conclusion for boards, General Counsel and investors is that an MBO should not be viewed simply as a tender offer at a premium. The board must decide whether going private is a credible route to enhancing corporate value, whether general shareholders receive a fair share of that value, whether the terms were produced by an independent and informed process, whether shareholders can evaluate the transaction on adequate information, and whether the same decision can be explained to a court after closing. The 2025 TSE reforms and the Supreme Court decision examined above both point toward the same direction: substance matters more than the presence of formal devices. Japanese MBO law and practice are increasingly about designing a decision that deserves to be implemented, not merely administering the steps needed to implement it.
Frequently Asked Questions
Q1. When should a special committee be established after an MBO proposal is received?
METI’s Fair M&A Guidelines contemplate establishment of a special committee as promptly as practicable once the target receives a concrete, feasible and bona fide acquisition proposal. Waiting until the final price and principal terms have effectively been agreed may deprive the committee of meaningful negotiating room. Conflict management should begin when the transaction becomes sufficiently concrete to affect decision-making, not only when a final written offer is ready for board approval. [4]
Q2. Must the special committee consist only of independent outside directors?
No uniform statutory rule requires that composition in every case. TSE’s framework contemplates a committee made up of persons independent of the acquirer and the outcome of the transaction, including independent outside directors, outside statutory auditors and, where appropriate, outside experts. Independent outside directors are often the core members because they understand the company and its board. The analysis should nevertheless test substantive independence, including compensation arrangements, continuing business relationships and relationships with the buyer or financing sources. [5]
Q3. Can a CEO who intends to participate in the MBO negotiate the price on behalf of the target?
Participation should be approached with particular caution because MBO management may share an economic interest with the buyer. Management may still need to provide business information and explain the company’s operating plan, but information provision should be distinguished from authority to determine or negotiate the exit price for public shareholders. Meeting attendance, access to committee materials, negotiation channels and decision rights should be designed specifically for the conflict in the transaction.
Q4. Is an MBO fair if the offer price carries a substantial premium to market?
A premium is relevant but not conclusive. The company should consider whether the unaffected market price reflected objective value, whether the business plan omitted material value, how going-private benefits and synergies are allocated, whether credible alternatives existed and whether negotiations produced genuine improvements. Price fairness is assessed in the context of valuation, negotiation, alternatives, process and disclosure, rather than by a single premium percentage.
Q5. Are a majority-of-the-minority condition, market check or fairness opinion mandatory in every MBO?
No. The Fair M&A Guidelines favour selecting and combining safeguards in light of the strength of the conflict and the effectiveness of the overall process. A particular safeguard may become especially important where the controlling influence is strong or the committee has limited bargaining power, but Japanese law does not impose all of these measures as uniform statutory conditions for every MBO. The reasons for using or not using a material safeguard should be considered and documented.
Q6. If the buyer obtains 90% of the voting rights after the tender offer, can it complete the squeeze-out without another shareholders’ meeting?
Potentially. A holder of at least 90% of the voting rights may qualify as a special controlling shareholder and may use the demand-for-share-cash-out procedure under Articles 179 et seq. of the Companies Act, subject to the statutory conditions and target approval process. Remaining shareholders retain specified remedies, including potential injunctive relief and a right to seek court determination of the sale price. If the 90% threshold is not met, a consolidation of shares requiring a special resolution is commonly used instead. The analysis must also check whether the articles prescribe a higher percentage and whether statutory aggregation with qualifying wholly owned entities is relevant. [1]
Q7. Must the cash amount in the squeeze-out equal the tender offer price?
Japanese going-private transactions commonly structure the second-step cash-out so that shareholders who did not tender receive an amount based on the same per-share price as tendering shareholders. That promotes equal treatment and transaction coherence. It does not, however, cure defects in the formation of the tender offer price itself. If the first-step price or process is challenged, the issue may carry into the squeeze-out through appraisal or price-determination proceedings.
Q8. Can the July 1, 2016 decision be applied mechanically to a modern squeeze-out?
No. It determined the price of a post-tender acquisition of shares subject to a class-wide acquisition provision under the former Article 172. Conflict safeguards, advance disclosure of equal pricing and relevant changes in circumstances remain important analytical considerations, but the decision does not replace the statutory conditions or remedies governing modern share cash-outs or consolidations. Establishing a committee alone does not guarantee judicial respect for a price. [6]
Q9. Does establishing a special committee prevent appraisal or other shareholder litigation?
No. A special committee is a mechanism for producing a fair decision, not a formal immunity from challenge. If the committee lacks independence, receives incomplete information, does not negotiate, is brought in after the outcome is effectively fixed or supports inadequate disclosure, the fact that a committee existed may carry limited weight. A genuinely independent process and a coherent contemporaneous record can materially improve the company’s ability to explain and defend the transaction, but they do not eliminate statutory shareholder rights.
Q10. What should an overseas private equity sponsor focus on when taking a Japanese listed company private with management participation?
The sponsor should integrate Japan’s tender offer rules, TSE requirements and Companies Act squeeze-out mechanics with management rollover and incentive arrangements, financing, foreign investment review under the Foreign Exchange and Foreign Trade Act, competition law and any sector-specific approvals. Particular care should be taken over the timing and content of management arrangements so that the target’s special committee retains genuine ability to negotiate for public shareholders. Clear information and negotiation protocols among the sponsor, lenders, target, committee and advisers are critical to deal certainty.
Q11. Are TSE’s July 2026 minority-shareholder protection reforms already fully applicable?
The rule changes were adopted in July 2026, but certain elements have future application dates. In particular, aspects relating to disclosure of minority-shareholder support and the revised independence framework apply in stages, including from annual general meetings for fiscal years ending on or after December 1, 2026. As of October 7, 2026, transaction teams should distinguish provisions already effective from provisions that have been adopted but are not yet applicable to the relevant company or meeting. [7] [8]
About the Legal Update Series
SAKURA Law Office and Managing Partner Kenshiro Michishita publish the Legal Update series on corporate law, M&A and private equity, financial regulation and capital markets, cross-border transactions, international disputes, corporate crisis management, AI and technology, data protection, Web3 and digital assets, employment, reputation and corporate governance. The series is designed not merely to summarise legislation or regulatory announcements, but to connect legal rules with the decisions that boards, General Counsel, executives, financial institutions, sponsors and overseas counsel must make in transactions, governance and disputes.
For further information, please see the SAKURA Law Office official website, the profile of Managing Partner Kenshiro Michishita and the firm’s M&A and Business Succession practice page.
How SAKURA Law Office Can Assist
SAKURA Law Office advises on MBOs, acquisitions of listed subsidiaries by controlling shareholders, other going-private transactions and private-equity-led tender offers for an acquirer or a target, subject to applicable conflict checks. The firm can assist with transaction structuring, tender offer regulation, Companies Act procedures, formation and operation of special committees, management of board conflicts, allocation of roles among financial and legal advisers, price and term negotiations, timely disclosure, squeeze-out mechanics, shareholder meetings and closing execution.
For targets and special committees, key workstreams may include the response to an initial acquisition proposal, committee mandate and authority, independence analysis for proposed committee members, legal review of the standalone business plan and valuation process, treatment of competing proposals and market checks, negotiation governance, and review of the committee opinion and public disclosure. For acquirers and private equity sponsors, the issues commonly include management approaches and rollover arrangements, financing, tender offer conditions, engagement with the target’s independent process, foreign investment and competition review, and coordinated planning for both the 90%-plus and below-90% squeeze-out routes.
Where shareholder disputes arise, the same transaction record becomes central to proceedings involving a demand for share cash-out, consolidation of shares, statutory appraisal, court determination of price or injunctive relief. Early process design can therefore serve both transactional execution and dispute preparedness. In cross-border matters, coordination among the overseas sponsor or strategic buyer, Japanese target, financial institutions and foreign counsel is often necessary to align Japanese-law requirements with the global transaction timetable.
Contact
SAKURA Law Office
Ark Hills South Tower 4F, 1-4-5 Roppongi, Minato-ku, Tokyo 106-0032, Japan
Managing Partner Kenshiro Michishita
Official website | Kenshiro Michishita — Profile | Contact form
Principal References
The numbered references in the text correspond to the materials below. Statutes, exchange rules, judgments, administrative guidance and practical recommendations have different legal status.
1. e-Gov Laws | Companies Act, Act No. 86 of 2005 (Japanese statutory text)
2. e-Gov Laws | Financial Instruments and Exchange Act, Act No. 25 of 1948 (Japanese statutory text)
8. TSE | Disclosure of minority-shareholder approval percentages and related information (Japanese)
10. FSA / TSE | Corporate Governance Code, 2026 revision (Japanese original PDF)
Disclaimer
This Legal Update is based on statutes, court decisions, regulatory materials, Tokyo Stock Exchange rules and other public information available as of October 7, 2026 and is prepared solely for general informational purposes. It does not constitute legal advice or a legal conclusion concerning any specific transaction. The legal analysis of an MBO, tender offer, demand for share cash-out, consolidation of shares, corporate reorganisation, appraisal proceeding or other going-private transaction depends on the parties, shareholding structure, transaction sequence, tender conditions, relationships among shareholders and directors, applicable sector regulation, foreign investment and competition review, business plan, valuation assumptions and disclosure record.
Certain elements of TSE’s July 2026 minority-shareholder protection reforms apply from future dates, including measures that apply by reference to annual general meetings for fiscal years ending on or after December 1, 2026. This Update distinguishes, at a high level, between rules already in force and provisions adopted but not yet applicable as of the cut-off date. Listing rules, enforcement rules, practical guidance, tender offer regulations and other relevant materials may continue to change. Transaction parties should confirm the latest Japanese statutory text, exchange rules and official guidance at the time of any proposed transaction. English translations of Japanese statutes and regulatory materials are generally provided for reference; the Japanese originals prevail for purposes of interpretation and application.
The July 1, 2016 Supreme Court decision discussed here concerns a class-wide acquisition price proceeding under the former Article 172 of the Companies Act. It does not establish that the same result necessarily follows under Articles 179 et seq. or in a share consolidation. The Court’s holding must be distinguished from this Update’s practical analysis of transaction design, disclosure and contemporaneous records.